Welcome to our dedicated page for Bruker SEC filings (Ticker: BRKR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bruker Corporation filings document financial results, capital returns, governance actions and proxy matters for a scientific instruments and diagnostics company.
Recent Form 8-K disclosures cover quarterly and annual operating results, outlook commentary, segment information for Bruker Scientific Instruments and Bruker Energy & Supercon Technologies, and dividends on common stock and 6.375% Mandatory Convertible Preferred Stock, Series A. The definitive proxy statement covers board elections, executive compensation, pay-versus-performance data, shareholder voting items and governance practices. Other material-event filings record board composition changes and executive transition arrangements.
Herman Gerald N., Executive Vice President and CFO of Bruker Corporation, reported the withholding of vested restricted stock units to satisfy tax obligations. The Form 4 shows three withholding transactions over August 9–11, 2025: 1,846 shares on 08/09 at $30.43, 1,380 shares on 08/10 at $30.43, and 1,420 shares on 08/11 at $30.78. The company’s explanatory note states these shares were withheld to cover taxes arising from vesting of previously granted RSUs.
Following the reported transactions, the filing lists beneficial ownership declining across those dates to 79,539, then 78,159, and finally 76,739 shares held directly by the reporting person. These entries are recorded under Transaction Code F and are presented as direct ownership on the Form 4.